Position history for BlackRock, Inc.'s holdings in CANDEL THERAPEUTICS INC
BlackRock, Inc. holds 3.1M shares of CADL (CANDEL THERAPEUTICS INC), worth $15.2M as of 2026-Q1. The position was increased (+8.6% shares). CADL represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$15.2M
Current Shares
3.1M
Total Value Change
+$5M
Total Shares Change
+1.9M
Other major holders of CADL: FMR LLC
Increased |
| 3.1M |
+8.6% |
| $15.2M |
| 0.0% |
| $4.91 |
31 |
| 2025-Q4 | Increased | 2.9M | +20.3% | $16.2M | 0.0% | $5.71 | 34 |
| 2025-Q3 | Increased | 2.4M | +3.4% | $12.1M | 0.0% | $5.40 | 29 |
| 2025-Q2 | Increased | 2.3M | +30.5% | $11.6M | 0.0% | $4.90 | 35 |
| 2025-Q1 | Increased | 1.8M | +49.0% | $10M | 0.0% | $5.95 | 38 |
| 2024-Q4 | New | 1.2M | - | $10.3M | 0.0% | $7.95 | 38 |